Thus, some studies report that HDAC inhibitors promote β-cell development and proliferation and might potentially therefore be a novel treatment for diabetes [56,57,58], whereas our data indicated no effect of 1 μM SAHA on mouse epidermal keratinocyte proliferation (Figure 8). The gene discussed is HDAC9; the disease is diabetes mellitus.